Article Information
History
- May 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rayan Khaddaj-Mallat1,3,
- Natija Aldib1,2,3,
- Anne-Sophie Paquette1,3,
- Aymeric Ferreira2,3,
- Sarah Lecordier1,3,
- Maxime Bernard1,3,
- Armen Saghatelyan2,3 and
- Ayman ElAli1,3,*
- 1Neuroscience Axis, Research Center of CHU de Québec - Université Laval, Quebec City, QC, Canada
- 2Research Center CERVO, Quebec City, QC, Canada
- 3Department of Psychiatry and Neuroscience, Faculty of Medicine, Université Laval, Quebec City, QC, Canada
- ↵*Correspondence: Dr Ayman ElAli, Neuroscience Axis (T2-33), Research Center of CHU de Québec-Université Laval 2705 Laurier Boulevard, Quebec City, QC, G1V 4G2, Canada, E-mail: ayman.el-ali{at}crchudequebec.ulaval.ca
Posted May 03, 2021.
SARS-CoV-2 spike protein induces brain pericyte immunoreactivity in absence of productive viral infection
